BAX 855

Playing defense, Baxalta makes its case for a new hemophilia drug
Fierce Biotech
Thu, 07/16/15 - 04:52 pm
Baxalta
hemophilia A
BAX 855
Advate
Long-acting version of Baxter's hemophilia drug succeeds in study
Yahoo/Reuters
Thu, 08/21/14 - 11:38 am
Baxter International
Advate
hemophilia A
BAX 855
4 Healthcare Stock Stories Making Midweek Headlines
Wall St Cheat Sheet
Thu, 11/14/13 - 10:15 am
BAX 855
Baxter International
plecanatide
Synergy Pharmaceuticals
layoffs
Transcept
NPS Pharmaceuticals
Gattex